Fact-checked by Grok 2 weeks ago

Tree-in-bud sign

The tree-in-bud sign is a distinctive radiologic observed on thin-section computed () scans of the lungs, characterized by multiple small centrilobular nodules of soft-tissue connected to branching linear structures, morphologically resembling the twigs of a tree. This appearance arises from impaction of the distal bronchioles (typically 0.2–1 mm in diameter) with mucus, pus, fluid, or cellular debris, which outlines their normally invisible branching architecture and signifies underlying small airways disease. First described in the context of endobronchial spread of , the sign is nonspecific but highly suggestive of or bronchiolectasis when present in a peripheral, centrilobular distribution. The tree-in-bud pattern is most commonly associated with infectious etiologies, including bacterial infections such as (seen in approximately 5% of post-primary cases), , and ; viral infections like or adenovirus in immunocompromised patients; and fungal or parasitic processes such as or . Noninfectious causes are also frequent and include congenital disorders like or , idiopathic conditions such as diffuse panbronchiolitis or obliterative bronchiolitis, immunologic disorders including , connective tissue diseases like or , and even neoplastic emboli from tumors such as . Accompanying imaging features, such as bronchial wall thickening, mucous plugging, or cavitation, along with the patient's clinical history (e.g., or exposure risks), are essential for narrowing the . Clinically, the tree-in-bud sign serves as an important indicator of active airway , prompting further evaluation with , , or to identify the underlying cause, particularly in cases of persistent , fever, or dyspnea. Its recognition on is crucial for early intervention, as many associated conditions are treatable if addressed promptly, though varies widely depending on the —from self-limited viral to progressive fibrotic diseases.

Description

Definition

The tree-in-bud sign is a nonspecific radiological finding observed on thin-section (CT) scans of the lungs, characterized by multiple small centrilobular nodules of soft-tissue connected to branching linear opacities that originate from the nodules and extend proximally toward the hilum. This pattern derives its name from its visual resemblance to the budding branches of a tree, with the nodules representing the "buds" and the linear structures mimicking the branching twigs. The sign indicates underlying small airway pathology, typically involving bronchiolar luminal impaction with , , fluid, or cellular debris, which outlines the otherwise invisible distal airways and reflects obstruction or in the peripheral zones. It is most commonly associated with , endobronchial spread of infectious processes, or chronic aspiration, though it remains a descriptive term rather than a specific . The term "tree-in-bud sign" was first described in 1993 by Im et al. in the context of endobronchial spread of pulmonary on , building on earlier observations of similar appearances in infectious diseases dating back to the late .

Imaging Characteristics

The tree-in-bud sign is primarily observed on (HRCT) scans of the chest, where thin sections of 1-2 mm thickness enable optimal visualization of small airway structures that would otherwise be obscured on thicker slices or conventional . This highlights the sign's characteristic appearance, consisting of multiple small centrilobular nodules, typically 2-4 mm in diameter, connected to linear branching opacities that extend centripetally toward the hilum, mimicking the branching of a budding tree and often clustered in affected secondary pulmonary lobules. These nodules represent soft-tissue within the bronchioles, while the branching elements reflect dilated or impacted peripheral airways. The distribution of the tree-in-bud pattern is characteristically peripheral and centrilobular, sparing the pleural surface directly but located within 5 mm of it, with a predilection for the lower lung lobes due to gravitational effects in dependent regions. It may manifest focally, confined to a single lobe or segment as seen in localized infections, or diffusely across multiple lobes in widespread processes. This zonal preference aids in distinguishing it from more random or upper lobe-dominant patterns in other pathologies. In acute infectious scenarios, the tree-in-bud sign can evolve over time, transitioning from isolated nodular and branching opacities to more consolidated patterns as and spread beyond the bronchioles. Severity assessment in associated conditions like , where the sign frequently coexists, may incorporate scoring systems such as the Reiff score, which evaluates extent and degree of involvement across lobes to quantify overall . This progression underscores the sign's utility in serial imaging for dynamic airway disease.

Pathophysiology

Mechanisms

The tree-in-bud sign arises primarily from impaction of small airways, specifically bronchioles with diameters less than 2 mm, by , , inflammatory cells, or cellular debris, leading to bronchiolar dilatation and the formation of nodular beading along branching structures. This impaction causes the linear and nodular opacities visible on (HRCT), where the "tree" component represents the dilated bronchioles filled with material, and the "buds" correspond to adjacent alveolar ducts or clustered inflammatory foci. In infectious and inflammatory contexts, such as , this process often begins with endobronchial spread or , resulting in epithelial damage and accumulation of exudates within the . The centrilobular distribution of the tree-in-bud pattern reflects involvement of the terminal and respiratory bronchioles, which are located at the center of secondary pulmonary lobules and supplied by centrilobular branches of the pulmonary arterioles. These structures, lacking and reliant on for patency, become prone to obstruction when impacted, producing the characteristic branching appearance in a peripheral, lobular-centric pattern on . Peribronchiolar further accentuates this by extending to adjacent alveoli, creating clustered micronodules that mimic budding twigs. An underlying inflammatory response contributes to bronchiolar wall thickening through mechanisms including , infiltration by lymphocytes, plasma cells, histiocytes, and other inflammatory cells, or in chronic or recurrent cases. This thickening narrows the airway , exacerbating impaction and promoting a vicious cycle of and obstruction. In conditions impairing , such as those involving ciliary dysfunction or excessive mucus production, stagnant secretions accumulate, fostering bacterial overgrowth and perpetuating the branching opacities that define the sign.

Anatomical Basis

The tree-in-bud sign originates from pathological changes within the pulmonary acinar units, which are the functional components of gas exchange located in the centrilobular regions of the secondary pulmonary lobule. These lobules, measuring approximately 1–2.5 cm in diameter, consist of 3–5 terminal bronchioles and their associated acini, with the acinus itself having an average diameter of about 7 mm. The pattern manifests as small centrilobular nodules (typically 2–4 mm) connected by branching linear opacities, reflecting involvement of the distal airways and adjacent structures in these peripheral zones of the lobule. This imaging appearance primarily involves the small airways, specifically the bronchioles, which are airways less than 2 mm in diameter lacking cartilaginous support. Without cartilage, bronchioles are highly compliant and susceptible to collapse or obstruction from inflammatory exudate, mucus, or cellular debris, leading to the characteristic branching morphology that mimics a budding tree. The centrilobular bronchiole, originating from the lobular core, branches into respiratory bronchioles within the acinus, amplifying the visibility of these changes on high-resolution CT. The tree-in-bud pattern correlates closely with the pulmonary vasculature, as the affected bronchioles are accompanied by centrilobular arteries in the bronchovascular bundle at the center of the secondary lobule. This anatomic proximity results in nodules and branches that appear clustered around these vessels, distinguishing the centrilobular distribution from perilymphatic nodules (which align along interlobular and fissures) or random nodules (diffusely scattered, as in miliary ). Such vascular association underscores the pattern's utility in localizing airway-centric pathology. The distribution of the tree-in-bud sign often shows peripheral and basal predominance, attributable to the 's gravitational gradients and pathways of pathological spread. In the upright position, dependent lower lobes experience increased risk, promoting endobronchial deposition in peripheral bronchioles. Hematogenous can similarly favor basal zones due to higher blood flow in dependent regions, though the pattern remains centrilobular rather than purely random. This zonal preference enhances diagnostic specificity when correlated with clinical context.

Etiology

Infectious Causes

The tree-in-bud sign most frequently arises from infectious etiologies involving endobronchial spread within the small airways, with mycobacterial infections being the predominant cause globally. is the classic pathogen, particularly in postprimary tuberculosis, where it manifests as due to hematogenous or bronchial dissemination, often accompanied by cavitary lesions in the upper lobes. This pattern indicates active, and is commonly observed in cases with endobronchial spread on high-resolution CT. , such as (), are increasingly recognized, especially in immunocompromised individuals, where they cause similar bronchiolar impaction with and inflammatory , leading to the branching nodular appearance. Bacterial infections contribute significantly through endobronchial spread in or events. Pathogens like and can produce the tree-in-bud pattern via , particularly in cases of bacterial following viral illness. Anaerobic bacteria from , common in debilitated patients, result in peripheral tree-in-bud opacities due to polymicrobial involvement of the bronchioles. similarly presents with this sign, often in hospitalized or post-influenza settings. Viral infections, though less common than bacterial or mycobacterial causes, can induce the tree-in-bud sign through in susceptible populations. (RSV) is a frequent culprit in infants, causing small airway inflammation with centrilobular nodules and branching structures. Adenovirus and viruses produce similar patterns in adults, particularly during outbreaks, by direct epithelial damage and secondary bacterial involvement. in immunocompromised hosts, such as transplant recipients, leads to endobronchial dissemination mimicking bacterial disease. Post-2020 data indicate heightened associations with etiologies, including where vascular tree-in-bud patterns can emerge in severe acute cases, potentially reflecting distal vascular involvement. Fungal and parasitic infections are rarer but notable in specific contexts, often in immunocompromised or endemic settings. Invasive , caused by species, presents with tree-in-bud opacities alongside and signs in neutropenic patients, due to angioinvasive . similarly involves endobronchial spread, producing branching nodules in diabetic or transplant populations. Parasitic causes, such as hydatid disease from , can exhibit the sign following cyst rupture and secondary bacterial superinfection, leading to endobronchial dissemination in endemic regions like the Mediterranean or . Epidemiologically, the tree-in-bud sign's infectious causes show marked geographic variation, with mycobacterial infections predominating in tuberculosis-endemic areas such as and . In low-prevalence regions like , nontuberculous mycobacteria account for a larger proportion among immunocompromised patients. Overall, infections represent over 70% of tree-in-bud etiologies across studies, with bacterial and viral causes more prevalent in pediatric and community settings.

Noninfectious Causes

Noninfectious causes of the tree-in-bud sign on high-resolution (HRCT) encompass a range of conditions involving small airway , obstruction, or vascular involvement, often mimicking infectious etiologies but arising from mechanical, immunologic, neoplastic, or toxic processes. These are less common than infections but critical for , particularly in patients with chronic comorbidities or exposure histories. Chronic microaspiration, frequently associated with () or swallowing disorders, leads to chemical characterized by recurrent inhalation of gastric contents or oral secretions, resulting in bronchiolar inflammation and mucoid impaction that manifests as basilar-predominant tree-in-bud opacities on . Predisposing factors include esophageal dysmotility or neurologic impairments, with often showing associated bronchial wall thickening and . In immunodeficiency states, such as infection or post-transplant settings, organizing pneumonia or can produce tree-in-bud patterns due to lymphocytic infiltration and fibrotic narrowing of small airways. , triggered by inhalational antigens like organic dusts or bird proteins, causes bronchiolocentric inflammation with centrilobular nodules and branching opacities, typically in a mid-to-upper zone distribution. Neoplastic processes, including endobronchial metastases or (formerly bronchioloalveolar carcinoma), may exhibit tree-in-bud appearances through tumor emboli occluding small pulmonary arteries or lepidic spread along alveolar walls leading to bronchiolar mucoid impaction. These are often peripheral and multifocal, with associated ground-glass opacities or signaling underlying . Inflammatory conditions linked to diseases, such as or Sjögren's syndrome, can induce follicular via peribronchiolar , producing centrilobular nodules and tree-in-bud opacities alongside mosaic attenuation from . , a congenital disorder, promotes and mucus plugging in small airways, yielding tree-in-bud patterns often with upper lobe predominance and associated cystic changes. Iatrogenic causes include radiation-induced lung injury, where bronchiolar damage from radiotherapy results in inflammatory exudates and tree-in-bud opacities within the port, typically appearing 1-3 months post-treatment and resolving with time. Drug toxicity, exemplified by , may rarely present with bronchiolitis-like patterns including tree-in-bud due to phospholipidosis and interstitial , though more commonly featuring ground-glass opacities.

Diagnosis

Detection Techniques

The primary modality for detecting the tree-in-bud sign is (HRCT) of the chest, which employs volumetric acquisition with thin-section imaging (typically 0.5–1.5 mm slice thickness) to achieve high for visualizing small airway abnormalities. Multiplanar reconstructions, including coronal and sagittal views, are routinely generated from the volumetric data to facilitate comprehensive assessment of branching nodular patterns in multiple orientations. This approach allows for full coverage without gaps, improving detection compared to older spaced-section techniques. HRCT protocols for suspected small airway disease generally include scans at full inspiration to optimize lung expansion, with additional expiratory phase at end-expiration (near residual volume) to evaluate for , which often accompanies the tree-in-bud pattern. Prone positioning during scanning is recommended in cases of basal-predominant findings to distinguish true parenchymal abnormalities from gravity-dependent , as dependent opacities may resolve or redistribute in the . Advanced post-processing software, such as computer-aided detection (CAD) systems, can assist in automated nodule identification, quantification, and volumetry, enhancing objectivity in subtle or multifocal cases. Adjunct imaging modalities include conventional multidetector CT (MDCT), which offers similar resolution but may use thicker slices (1–2 mm at 10 mm intervals) for broader coverage in resource-limited settings, though it is less optimal for fine detail. Chest radiography is far less sensitive, often failing to resolve the subtle nodular and branching opacities of the tree-in-bud sign and instead showing only nonspecific hazy or nodular patterns in advanced disease. tomography-computed (PET-CT) serves as a targeted adjunct when is suspected, as it can highlight hypermetabolic activity in neoplastic causes of the sign, such as bronchioloalveolar or tumor emboli, guiding decisions. HRCT is highly sensitive for detecting the tree-in-bud sign, particularly in moderate to severe cases involving endobronchial spread or inflammation, though early or mild presentations may show focal findings obscured by overlying structures. Limitations include , which can be mitigated with low-dose protocols (≤80 mAs), and the need for correlation with clinical history to avoid overinterpretation of benign variants.

Interpretation

The tree-in-bud sign is recognized on (HRCT) as multiple small centrilobular nodules (typically 2-4 mm in diameter) connected to linear branching opacities originating from the center of the secondary pulmonary lobule, creating a characteristic appearance of a . This pattern must be distinguished from non-branching random centrilobular nodules, which lack the linear connections and may represent hematogenous spread or "tree-in-bloom" appearances seen in conditions like vaping-associated lung injury, as well as from mosaic attenuation, which exhibits patchy areas of varying lung density due to or abnormalities without nodular components. To quantify the extent of the tree-in-bud pattern, particularly in chronic conditions like , scoring systems such as the Bhalla score are employed, which assess the distribution and severity of associated bronchial abnormalities including mucus plugging and manifestations across lung lobes. Contextual evaluation enhances interpretation by considering accompanying radiographic features, which can narrow the . For instance, the presence of ground-glass opacities or often indicates an acute infectious or inflammatory process affecting the alveoli alongside bronchiolar involvement, while may suggest a systemic or granulomatous condition such as or . These associated findings, when correlated with the predominantly peripheral and basal distribution of the tree-in-bud pattern, help guide further diagnostic pursuits. Reporting of the -in-bud sign follows standardized terminology outlined in the Fleischner Society , which defines it as micronodules with branching linear opacities resembling a , emphasizing its indication of small airway disease. For incidental detections, guidelines recommend multidisciplinary integration, incorporating clinical history, pulmonary function tests, and microbiological studies such as cultures to determine the underlying cause and appropriate management. Common pitfalls in interpretation include technical artifacts from patient motion, which can produce or branching-like opacities mimicking the pattern, and reconstruction artifacts in low-dose scans that may obscure or exaggerate small airway details. Additionally, as should be avoided in smokers, where ill-defined centrilobular nodules from respiratory bronchiolitis-associated can resemble early tree-in-bud but typically lack the prominent branching and are upper lobe-predominant without infectious context.

Clinical Significance

Associated Conditions

The tree-in-bud sign on (HRCT) of the lungs is frequently associated with respiratory symptoms that reflect small airway and obstruction. In acute infectious processes, such as bacterial or viral , patients commonly present with cough, dyspnea, and occasionally , particularly in cases involving endobronchial spread like nontuberculous mycobacterial infections or . In chronic conditions like , the sign correlates with recurrent exacerbations characterized by persistent productive cough and progressive dyspnea, often exacerbated by mucus impaction and repeated infections. This imaging finding is more prevalent in certain patient demographics, including elderly individuals, smokers, and those with underlying comorbidities that predispose to airway disease. Immunosuppressed patients, such as those with or post-transplant status, are at higher risk due to opportunistic infections manifesting as tree-in-bud opacities. Comorbidities like (COPD) further increase susceptibility, with tree-in-bud patterns commonly observed in patients with COPD and nontuberculous mycobacterial lung disease. Systemic involvement accompanies the tree-in-bud sign in several etiologies, highlighting its role in broader clinical syndromes. In pulmonary , the pattern often occurs alongside constitutional symptoms such as fever, , and significant , reflecting disseminated endobronchial infection. Similarly, in rheumatoid arthritis-associated , patients may experience low-grade fever, , , and joint pains, with the imaging sign indicating follicular bronchiolitis or organizing pneumonia as extra-articular manifestations. Comorbidities involving parenchymal remodeling, such as or , can overlap with tree-in-bud opacities, amplifying respiratory compromise through combined obstructive and restrictive physiology. In post-viral syndromes like , the sign appears in sequelae of constrictive , associated with persistent dyspnea and fibrotic changes, which are reported in up to 33% of survivors at six months post-infection, particularly among those requiring intensive care.

Prognostic Implications

The tree-in-bud sign often correlates with disease severity, particularly in conditions like cystic fibrosis, where its presence is associated with reduced forced expiratory volume in 1 second (FEV1), indicating poorer lung function on univariate analysis. Extensive involvement, such as diffuse or multifocal patterns, suggests more advanced small airway obstruction and inflammation, which can impair overall respiratory performance. Resolution of the sign following appropriate therapy, such as antibiotics in infectious cases, serves as a positive indicator of treatment response and potential functional recovery. In pulmonary , the tree-in-bud sign reflects active endobronchial spread and , but early detection and initiation of antituberculous can lead to of centrilobular opacities within approximately 5 months, improving cure rates and reducing risk. Conversely, in nontuberculous mycobacterial infections, persistence of the sign is indicative of chronicity, particularly in the nodular bronchiectatic subtype, which, while often indolent, requires prolonged treatment and may signal ongoing or poor microbiological clearance. This chronic pattern underscores the need for vigilant follow-up to prevent exacerbation. The presence of the tree-in-bud sign guides management by prompting targeted interventions based on ; for suspected infectious causes, empirical antibiotics are initiated, while neoplastic or atypical presentations necessitate with to confirm and exclude . In inflammatory conditions, such as those related to diseases, immunosuppressants may be considered to address underlying . Long-term, the sign raises concerns for progression to irreversible structural changes, including and peribronchial , especially in post-treatment or chronic infections like , where serial high-resolution monitoring helps detect early complications and informs adjustments in therapy to mitigate decline.

Differential Diagnosis

Key Distinctions

The tree-in-bud pattern is characterized by centrilobular nodules connected by branching linear opacities, reflecting small airway disease, which differentiates it from centrilobular . In contrast, centrilobular manifests as focal areas of low attenuation with thin walls or no walls, indicating parenchymal destruction without the branching structures typical of tree-in-bud. Unlike mosaic perfusion, which presents as patchy areas of heterogeneous lung due to or vascular abnormalities and often reverses on expiratory imaging, the tree-in-bud sign features discrete centrilobular nodules and linear branching without such reversibility. Mosaic perfusion lacks the nodular and branching components central to tree-in-bud. Perilymphatic nodules, commonly associated with , distribute along lymphatics including pleural surfaces, interlobular septa, and fissures, showing a beaded appearance in these locations. Tree-in-bud, however, remains strictly centrilobular, sparing immediate subpleural regions and lacking this lymphatic alignment. In terms of distribution, the tree-in-bud pattern is acinar-centric and centrilobular, originating from bronchioloalveolar units within secondary pulmonary lobules, typically 5–10 mm from pleural surfaces. This contrasts with random (hematogenous) patterns, which show diffuse, uniform miliary nodules without lobular preference, or perilymphatic distributions that favor subpleural and fissural locations.

Common Mimics

Similarly, may produce a tree-in-bud-like appearance due to bronchiolar and from chronic exposure, but it often manifests with diffuse, ill-defined centrilobular nodules and ground-glass opacities lacking prominent branching. Metastatic disease occasionally replicates the tree-in-bud sign via tumor emboli occluding small pulmonary arteries, leading to centrilobular nodules and branching opacities; however, these are usually larger (up to 1 cm), randomly distributed, and PET-avid, distinguishing them from infectious causes. Examples include emboli from breast carcinoma, , and gastric adenocarcinoma, where demonstrates beaded peripheral arteries and tree-in-bud opacities confirmed by . Eosinophilic pneumonia can exhibit tree-in-bud opacities from small airways involvement with centrilobular nodules, but this pattern is often overshadowed by predominant peripheral consolidations and ground-glass opacities. Congenital anomalies such as Williams-Campbell syndrome may simulate the tree-in-bud appearance through deficient cartilaginous support causing subsegmental bronchial collapse and nodularity along airways, though the findings are dynamic and vary with respiration on serial imaging. Imaging artifacts, including motion-related distortions or dependent opacities in positioning, can occasionally produce branching linear densities resembling tree-in-bud, particularly in the dependent regions, but these resolve on repeat scans or prone .

References

  1. [1]
  2. [2]
    Tree-In-Bud Pattern | AJR - American Journal of Roentgenology
    Tree-in-bud (Fig. 1) refers to a pattern seen on thin-section chest CT in which centrilobular bronchial dilatation and filling by mucus, pus, or fluid ...Infections · Fungal Infection · Idiopathic Disorders
  3. [3]
    Tree-in-bud pattern at thin-section CT of the lungs - PubMed
    The tree-in-bud pattern is commonly seen at thin-section computed tomography (CT) of the lungs. It consists of small centrilobular nodules of soft-tissue ...Missing: definition | Show results with:definition
  4. [4]
    None
    Nothing is retrieved...<|control11|><|separator|>
  5. [5]
  6. [6]
    Tree-in-bud pattern | Radiology Reference Article - Radiopaedia.org
    Aug 27, 2025 · Tree-in-bud pattern describes the CT appearance of multiple areas of centrilobular micronodules with a linear branching pattern, resembling a budding tree.On This Page · Pathology · Etiology
  7. [7]
    Correlating Reiff scores with clinical, functional, and prognostic factors
    May 14, 2024 · The severity of bronchiectasis was also categorized into three groups based on Reiff scores: Group 1 (mild: 1–6 points), Group 2 (moderate: 7–12 ...
  8. [8]
    Tree-in-Bud Pattern of Pulmonary Tuberculosis on Thin-Section CT
    Aug 6, 2018 · The “tree-in-bud-pattern” of images on thin-section lung CT is defined by centrilobular branching structures that resemble a budding tree.
  9. [9]
  10. [10]
    Special Considerations for Tree-in-Bud Nodules - ATS Journals
    Oct 30, 2018 · A tree-in-bud pattern of centrilobular nodules from metastatic disease occurs by two mechanisms: 1) direct filling of the centrilobular arteries ...
  11. [11]
    Pulmonary Functional Imaging: Part 1—State-of-the-Art Technical ...
    The secondary pulmonary lobules, measuring 1–2.5 cm in diameter ... Thin-section CT of the secondary pulmonary lobule: anatomy and the image—the 2004 Fleischner ...
  12. [12]
    Morphometry of the human pulmonary acinus - PubMed
    The morphological properties of pulmonary acini are described. The acinar volume averages 187 mm3 (SD +/- 79 mm3). Intraacinar airways branch dichotomously over ...
  13. [13]
    Anatomy, Thorax, Bronchial - StatPearls - NCBI Bookshelf - NIH
    As the bronchioles become smaller in width, they become terminal bronchioles which mark the end of the conducting zone of the respiratory system. The terminal ...
  14. [14]
    State of the Art: Imaging of Occupational Lung Disease
    Mar 3, 2014 · When evaluating nodular lung disease, distinction between centrilobular versus perilymphatic or random distribution is important. Centrilobular ...
  15. [15]
    Alveolar Pattern - PMC - PubMed Central - NIH
    Other causes of bronchiolar tree-in-bud sign: Aspiration: a gravitational and lower lung predominance of the tree-in-bud pattern is often observed.
  16. [16]
    High-resolution CT findings of pulmonary Mycobacterium ... - NIH
    The tree-in-bud sign, seen in 57% of TB cases, was a significant marker differentiating bacterial infection from TB in this series. Both of these studies ...
  17. [17]
    Causes and Imaging Patterns of Tree-in-Bud Opacities - CHEST
    Eisenhuber, E. The tree-in-bud sign. Radiology. 2002; 222:771-772. Crossref · Scopus (60) · PubMed · Google Scholar. 5. Hatipoğlu, ON ∙ Osma, E ∙ Manisali, M ...
  18. [18]
    'Tree-in-Bud': Thinking beyond Infectious Causes | Karger Publishers
    Jan 21, 2015 · The 'tree-in-bud' sign is an unspecific sign of bronchiolar and alveolar pathology. Many of the more common differential diagnoses, particularly ...<|control11|><|separator|>
  19. [19]
    Computed Tomography Vascular Tree-in-Bud: A Novel Prognostic ...
    Pulmonary vascular abnormalities were assessed by the presence of dilated peripheral vessels, identified as a vascular “tree-in-bud” pattern, as well as ...Missing: definition | Show results with:definition
  20. [20]
    CT imaging findings of invasive pulmonary fungal infections in ...
    Dec 12, 2024 · If it progresses, bronchiolitis develops, with mainly centrilobular nodules and branching opacities with a patchy “tree-in-bud” appearance [4].<|separator|>
  21. [21]
    Uncommon Presentation of a Pulmonary Hydatid Cyst: A Case Report
    Feb 28, 2025 · Loss of the lung parenchyma, the presence of air, and the tree-in-bud pattern indicating endobronchial spread of infection in the left lung were ...
  22. [22]
    The Spectrum of Lung Disease due to Chronic Occult Aspiration
    Oct 17, 2013 · On CT scan the disease usually presents as diffuse basilar centrilobular nodules and/or tree-in-bud pattern with airway and interstitial ...
  23. [23]
    Imaging of Hypersensitivity Pneumonitis - PMC - NIH
    ... tree-in-bud as well as centrilobular nodules (figure 11b). Figure 11. Figure ... This sign in the subacute or chronic setting is highly suggesting of HP.
  24. [24]
    Tree-in-Bud Pattern: Spectrum of Cause | AJR
    4. Hill CA. Bronchioloalveolar carcinoma: a review. Radiology 1984; 150:15–20. Crossref · PubMed · Google Scholar. Information & Authors. Information. Published ...<|separator|>
  25. [25]
    Radiation-induced Lung Disease and the Impact of ... - RSNA Journals
    (b) CT scan through the carina demonstrates nodular and tree-in-bud lesions (arrowhead) in the left upper lobe and in the superior segment of the left lower ...
  26. [26]
    HRCT Patterns of Drug-Induced Interstitial Lung Diseases: A Review
    Focal area of GGO (black arrowheads), centrilobular nodule, and the tree-in-bud pattern (asterisk) are visible in the right upper lobe. Alterations provoked by ...
  27. [27]
    Small airways diseases: detection and insights with computed ...
    HRCT appearances demonstrate more readily the pathological distribution of disease; there is a nodular pattern and small branching opacities (tree-in-bud ...
  28. [28]
    HRCT chest - prone (protocol) | Radiology Reference Article
    Mar 23, 2023 · The rationality behind it is to differentiate it from dependent lung atelectasis, which commonly presents as subpleural densities or lines.
  29. [29]
    Automatic Detection and Quantification of Tree-in-Bud (TIB ... - NIH
    TIB patterns, in particular, usually represent the disease of the small airways such as infectious-inflammatory bronchiolitis as well as bronchiolar luminal ...
  30. [30]
    Cystic fibrosis (pulmonary manifestations) - Radiopaedia.org
    Jun 25, 2024 · Chest radiographs are insensitive to the early changes of cystic fibrosis, with changes seen on HRCT in 65% of patients with CF and normal chest ...
  31. [31]
    Branches of Deception: A Tree-in-Bud Pattern Revealing Advanced ...
    Aug 25, 2025 · It is typically interpreted as a sign of endobronchial spread of infection, particularly mycobacterial or fungal etiologies, or aspiration [1].
  32. [32]
  33. [33]
    Respiratory bronchiolitis-interstitial lung disease
    Jul 11, 2014 · However, a tree-in-bud pattern, which is a common manifestation of small-airway-disease, was rarely reported [[43]]. The frequency of ...Missing: pitfalls artifacts reconstruction
  34. [34]
    Intermittent Cough and Hemoptysis With Tree-in-Bud Opacities on ...
    However, when patients are symptomatic, they generally present with nonspecific respiratory symptoms such as shortness of breath, dyspnea on exertion, cough,.
  35. [35]
    Case Report Productive cough and hemoptysis in elderly male with ...
    CT findings might show peribronchial consolidation/wall thickening, with centrilobular nodules and branching linear opacities known as “tree-in-bud” pattern.
  36. [36]
    Bronchiectasis: Causes, Symptoms, Treatment & Prevention
    Bronchiectasis is a condition where your airways widen or develop pouches. It causes coughing with a lot of mucus and frequent infections.Overview · Symptoms And Causes · Management And Treatment
  37. [37]
    Geriatric Chest Imaging: When and How to Image the Elderly Lung ...
    Jul 1, 2013 · In elderly patients, the immune system is often compromised. Beside ... tree-in-bud” pattern. If none of these previously mentioned ...6.1. Pneumonia · 6.3. Lung Changes With... · 6.5. Pulmonary Drug Toxicity
  38. [38]
    Clinical characteristics of patients with bronchiectasis with ...
    Dec 6, 2021 · 35.3%), tree-in-bud sign (97.9% vs. 29.0%), cavities (29.8% vs. 5.8 ... Nontuberculous mycobacterial lung disease in a patient with COPD and ...
  39. [39]
    Thoracic Manifestations of Rheumatoid Arthritis | RadioGraphics
    Jan 7, 2021 · The authors review the articular and extra-articular thoracic imaging manifestations of RA, including cardiovascular, respiratory, and pleural diseases.
  40. [40]
    Lung Fibrosis on CT Imaging: Essentials and Updates
    Nov 18, 2024 · It manifests as multifocal linear scarring, often accompanied by cylindrical bronchiectasis in the lower lungs and a “tree‑in‑bud” pattern [27].
  41. [41]
    What Are the Long-term Pulmonary Sequelae of COVID-19 Infection?
    On images, bronchiolitis and airway inflammation manifest as bronchial wall thickening, centrilobular nodules, and tree-in-bud opacities, whereas DAD manifests ...Missing: comorbidities | Show results with:comorbidities
  42. [42]
    Loss of FEV1 in cystic fibrosis: correlation with HRCT features
    The most common HRCT feature was bronchiectasis (98%) followed by atelectasis-consolidation (81%), bronchial wall thickening (77%), tree-in-bud sign (74%), ...
  43. [43]
    Outcomes of Mycobacterium avium complex lung disease based on ...
    The NB form occurs predominantly in postmenopausal, nonsmoking females [3] and can present as bilateral bronchiectasis with multiple nodules and tree-in-bud ...
  44. [44]
    [PDF] Utility of Bronchoscopy in Patients with Tree in Bud ... - Cronicon
    “The tree-in-bud sign”. Radiology 222.3 (2002): 771-772. 2. Miller WT Jr and JS Panosian. “Causes and imaging patterns of tree-in-bud opacities”. Chest ...
  45. [45]
    HRCT - Basic Interpretation - The Radiology Assistant
    Nov 3, 2025 · In the context of centrilobular nodules, the identification of the "tree-in-bud" pattern is valuable for narrowing the differential diagnosis.
  46. [46]
    [PDF] The Tree-in-Bud Pattern - Thieme Connect
    These findings could mimic those seen in asthma, panlobular emphysema, and neuroendocrine hyperplasia. • CT findings of bronchiolar disease are seen in. 10 to ...
  47. [47]
    Mimics in chest disease: interstitial opacities - Insights into Imaging
    Dec 18, 2012 · The most clinically important mimics of nodular with centrilobular tree-in-bud pattern are endobronchial spread of tuberculosis, atypical ...
  48. [48]
    A Review of Clinical and Imaging Findings in Eosinophilic Lung ...
    Finally, poorly defined centrilobular pulmonary nodules may be present, sometimes with a tree-in-bud pattern reflecting small airways involvement [44].
  49. [49]
    Williams–Campbell syndrome: a case report - PMC - PubMed Central
    Jan 11, 2012 · There was ground glass and tree-in-bud scattered in all lobes, a finding consistent with pneumonitis and acute bronchiolitis. Chest CT also ...Missing: mimics | Show results with:mimics
  50. [50]
    High-Resolution CT of the Lungs | AJR
    The two consistent components of high-resolution CT technique include the use of thin collimation, usually 1-2 mm, coupled with a high-spatial-frequency ...